Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis

MOTIVATION Most computational tools for small non-coding RNAs (sRNA) sequencing data analysis focus in microRNAs (miRNAs), overlooking other types of sRNAs that show multi-mapping hits. Here, we have developed a pipeline to non-redundantly quantify all types of sRNAs, and extract patterns of expression in biologically defined groups. We have used our tool to characterize and profile sRNAs in post-mortem brain samples of control individuals and Parkinson's disease (PD) cases at early-premotor and late-symptomatic stages. RESULTS Clusters of co-expressed sRNAs mapping onto tRNAs significantly separated premotor and motor cases from controls. A similar result was obtained using a matrix of miRNAs slightly varying in sequence (isomiRs). The present framework revealed sRNA alterations at premotor stages of PD, which might reflect initial pathogenic perturbations. This tool may be useful to discover sRNA expression patterns linked to different biological conditions. AVAILABILITY AND IMPLEMENTATION The full code is available at http://github.com/lpantano/seqbuster CONTACT lpantano@hsph.harvard.edu or eulalia.marti@crg.eu SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

[1]  Peter T Nelson,et al.  A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. , 2013, Journal of Alzheimer's disease : JAD.

[2]  Jianguo Xia,et al.  Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.

[3]  A. Hofman,et al.  Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[4]  Selene L. Fernandez-Valverde,et al.  Dynamic isomiR regulation in Drosophila development. , 2010, RNA.

[5]  E. Martens-Uzunova,et al.  Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer. , 2013, Cancer letters.

[6]  Xavier Estivill,et al.  A non-biased framework for the annotation and classification of the non-miRNA small RNA transcriptome , 2011, Bioinform..

[7]  E. Martin,et al.  Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease , 2011, PloS one.

[8]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[9]  T. Pan,et al.  Genome-wide Identification and Quantitative Analysis of Cleaved tRNA Fragments Induced by Cellular Stress* , 2012, The Journal of Biological Chemistry.

[10]  Markus Glatzel,et al.  CLP1 links tRNA metabolism to progressive motor-neuron loss , 2013, Nature.

[11]  David L. A. Wood,et al.  MicroRNAs and their isomiRs function cooperatively to target common biological pathways , 2011, Genome Biology.

[12]  H. Soreq Novel roles of non-coding brain RNAs in health and disease , 2014, Front. Mol. Neurosci..

[13]  Ana M. Aransay,et al.  miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments , 2011, Nucleic Acids Res..

[14]  Xavier Estivill,et al.  A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively parallel sequencing , 2010, Nucleic acids research.

[15]  G. Hannon,et al.  A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.

[16]  Ping He,et al.  MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein. , 2013, Human molecular genetics.

[17]  M. Tenenhaus,et al.  Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach , 2003, Human Genetics.

[18]  Xavier Estivill,et al.  MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. , 2011, Human molecular genetics.

[19]  N. Polacek,et al.  Slicing tRNAs to boost functional ncRNA diversity , 2013, RNA biology.

[20]  Chi-Ching Lee,et al.  DSAP: deep-sequencing small RNA analysis pipeline , 2010, Nucleic Acids Res..

[21]  H. Shill,et al.  Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology , 2014, PloS one.

[22]  G. Hutvagner,et al.  Small RNAs derived from the 5′ end of tRNA can inhibit protein translation in human cells , 2013, RNA biology.

[23]  Xavier Estivill,et al.  A highly expressed miR-101 isomiR is a functional silencing small RNA , 2013, BMC Genomics.

[24]  M. Schaefer,et al.  The RNA methyltransferase Dnmt2 is required for efficient Dicer-2-dependent siRNA pathway activity in Drosophila. , 2013, Cell reports.

[25]  Hansjürgen Bratzke,et al.  Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.

[26]  I. Ferrer,et al.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease , 2011, Journal of Neural Transmission.

[27]  G. Hutvagner,et al.  Transfer RNA‐derived fragments: origins, processing, and functions , 2011, Wiley interdisciplinary reviews. RNA.

[28]  Praveen Sethupathy,et al.  Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C , 2015, Scientific Reports.

[29]  David S. Greenberg,et al.  Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes , 2013, Front. Mol. Neurosci..

[30]  X. Estivill,et al.  Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction , 2013, RNA biology.

[31]  Xavier Estivill,et al.  SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells , 2009, Nucleic acids research.

[32]  J. Obeso,et al.  Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease , 2013, Cell Death and Disease.

[33]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[34]  E. Tolosa,et al.  MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder , 2015, Annals of neurology.

[35]  Pamela J Green,et al.  tRNA cleavage is a conserved response to oxidative stress in eukaryotes. , 2008, RNA.

[36]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[37]  Youri Hoogstrate,et al.  FlaiMapper: computational annotation of small ncRNA-derived fragments using RNA-seq high-throughput data , 2015, Bioinform..